Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Allograft rejection | R-HSA-9679028 | map05330 | lisinopril | 5362119 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | lisinopril | 5362119 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | lisinopril | 5362119 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | lisinopril | 5362119 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | lisinopril | 5362119 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | isosorbide | 3293 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | isosorbide | 3293 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | isosorbide | 3293 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | isosorbide | 3293 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | isosorbide | 3293 | drug-path |
| Endometrial cancer | R-HSA-2077421 | map05213 | isosorbide | 3293 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | isosorbide | 3293 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | tacrine | 1935 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | tacrine | 1935 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | tacrine | 1935 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | tacrine | 1935 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | tacrine | 1935 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | tacrine | 1935 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | altizide | 43672 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | altizide | 43672 | drug-path |